Nath Bio-Genes

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
171.15
-3.3 (-1.89%)
BSENSE

May 08

BSE+NSE Vol: 29.67 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
445.10
364.91
332.62
301.36
278.36
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
445.10
364.91
332.62
301.36
278.36
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
7.70
12.73
12.26
5.31
3.56
(Increase) / Decrease In Stocks
-112.38
-102.73
-21.16
11.98
4.99
Employee Cost
35.79
32.50
28.25
23.32
24.78
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
306.18
225.55
142.47
117.32
115.42
Selling and Distribution Expenses
122.43
116.97
93.00
70.83
68.38
Other Expenses
32.95
30.09
27.94
23.86
24.05
Total Expenditure (Excl Depreciation)
392.67
315.11
282.76
252.62
241.18
Operating Profit (PBDIT) excl Other Income
52.43
49.80
49.86
48.74
37.18
Other Income
7.81
4.55
0.63
0.55
1.85
Operating Profit (PBDIT)
60.24
54.35
50.49
49.29
39.03
Interest
15.99
10.48
9.11
10.12
10.61
Exceptional Items
6.01
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
50.26
43.87
41.38
39.17
-60.36
Depreciation
3.96
3.82
3.26
3.01
3.08
Profit Before Tax
46.30
40.04
38.12
36.16
-63.43
Tax
4.67
1.98
1.95
1.15
3.95
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
41.63
38.06
36.17
35.01
-67.39
Extraordinary Items
0.00
0.54
3.45
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
41.63
38.60
39.62
35.01
-67.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.02
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.63
38.60
39.62
35.03
-67.38
Equity Capital
19.00
19.00
19.00
19.00
19.00
Face Value
10.0
10.0
10.0
10.0
10.0
Reserves
661.45
625.38
590.91
554.17
526.94
Earnings per share (EPS)
21.91
20.32
20.85
18.44
-35.46
Diluted Earnings per share
20.98
20.14
21.34
18.44
-35.46
Operating Profit Margin (Excl OI)
11.78%
13.65%
14.99%
16.17%
13.36%
Gross Profit Margin
11.29%
12.02%
12.44%
13.0%
-21.68%
PAT Margin
9.35%
10.43%
10.87%
11.62%
-24.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 21.98% vs 9.71% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 7.85% vs -2.57% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 5.28% vs -0.12% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 52.58% vs 15.04% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Nath Bio-Genes With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
445.10
0
445.10
Other Operating Income
0.00
0.00
0.00
Total Operating income
445.10
0
445.10
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
7.70
0
7.70
(Increase) / Decrease In Stocks
-112.38
0
-112.38
Employee Cost
35.79
0
35.79
Power Cost
0.00
0
0.00
Manufacturing Expenses
306.18
0
306.18
Selling and Distribution Expenses
122.43
0
122.43
Other Expenses
32.95
0.00
32.95
Total Expenditure (Excl Depreciation)
392.67
0
392.67
Operating Profit (PBDIT) excl Other Income
52.43
0.00
52.43
Other Income
7.81
0
7.81
Operating Profit (PBDIT)
60.24
0
60.24
Interest
15.99
0
15.99
Exceptional Items
6.01
0
6.01
Gross Profit (PBDT)
50.26
0
50.26
Depreciation
3.96
0
3.96
Profit Before Tax
46.30
0
46.30
Tax
4.67
0
4.67
Provisions and contingencies
0.00
0
0.00
Profit After Tax
41.63
0
41.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
41.63
0
41.63
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.63
0
41.63
Equity Capital
19.00
0
19.00
Face Value
10.00
0
0.00
Reserves
661.45
0
661.45
Earnings per share (EPS)
21.91
0
21.91
Diluted Earnings per share
20.98
0
20.98
Operating Profit Margin (Excl OI)
11.78%
0%
0.00
11.78%
Gross Profit Margin
11.29%
0%
0.00
11.29%
PAT Margin
9.35%
0%
0.00
9.35%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 445.10 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 21.98% vs 9.71% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 41.63 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 7.85% vs -2.57% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 52.43 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5.28% vs -0.12% in Mar 2025

Annual - Interest
Interest 15.99 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 52.58% vs 15.04% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.78%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025